SIREN : 438186249
HOLDING ILOVEO is a French company founded 24 years ago, specialized in the sector Activités des sociétés holding. Based in GARDANNE (13120), this company of category PME shows in 2024 a revenue of 277 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 277 200 € | 273 000 € | 252 000 € | 252 000 € | 252 000 € | 240 000 € | 243 200 € | 307 450 € | 348 150 € |
| Net income | 170 166 € | -222 938 € | -33 141 € | 90 673 € | 77 667 € | -148 843 € | 62 205 € | 126 313 € | 37 648 € |
| EBITDA | 122 373 € | 112 272 € | 100 452 € | 102 515 € | 111 374 € | 88 922 € | 92 808 € | 72 757 € | 78 040 € |
| Net margin | 61.4% | -81.7% | -13.2% | 36.0% | 30.8% | -62.0% | 25.6% | 41.1% | 10.8% |
In 2024, HOLDING ILOVEO achieves revenue of 277 k€. Activity remains stable over the period (CAGR: -2.8%). Vs 2023: +2%. After deducting consumption (0 €), gross margin stands at 277 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 122 k€, representing 44.1% of revenue. Positive scissor effect: EBITDA margin improves by +3.0 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 170 k€, i.e. 61.4% of revenue. This profit can be retained or distributed to shareholders.
277 200 €
277 200 €
122 373 €
122 377 €
170 166 €
44.1%
The debt ratio (= Financial debt / Equity x 100) stands at 66%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 54%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 2.9 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 61.4% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
66.47%
53.798%
61.387%
2.94
In 2024, the debt ratio of HOLDING ILOVEO (66.47) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of HOLDING ILOVEO (53.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of HOLDING ILOVEO (2.94) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 12.51. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 21.3x. Operating income very largely covers interest expenses: high safety margin.
12.512
21.323
In 2024, the liquidity ratio of HOLDING ILOVEO (12.51) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
In 2024, the interest coverage of HOLDING ILOVEO (21.3x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 2197 days. Excellent situation: suppliers finance 2197 days of the operating cycle (retail model). WCR is negative (-77 days): operations structurally generate cash. Over 2016-2024, WCR increased by +44%, requiring additional financing.
-59 130 €
0 j
2197 j
0 j
-77 j
Based on 54 transactions of similar company sales
in 2024,
the value of HOLDING ILOVEO is estimated at
394 538 €
(range 112 237€ - 822 285€).
With an EBITDA of 122 373€, the sector multiple of 4.8x is applied.
The price/revenue ratio is 0.59x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 54 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare HOLDING ILOVEO with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sociétés holding
The revenue of HOLDING ILOVEO in 2024 is 277 k€.
Yes, HOLDING ILOVEO generated a net profit of 170 k€ in 2024.
The headquarters of HOLDING ILOVEO is located in GARDANNE (13120), in the department Bouches-du-Rhone.
The tax return of HOLDING ILOVEO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
HOLDING ILOVEO operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.